Povorcitinib beneficial for moderate-to-severe hidradenitis suppurativa
MedicalXpress
|
يول 28, 2026
For patients with moderate-to-severe hidradenitis suppurativa (HS), povorcitinib (an oral Janus kinase 1 inhibitor) is beneficial, according to a study published online July 23 in Nature Medicine.
This article was originally published by MedicalXpress. For more details, images, and references:
Read Full Original Article ↗